CRL Reports Officer/Director Changes, Compensation Arrangements
Ticker: CRL · Form: 8-K · Filed: Jan 24, 2024 · CIK: 1100682
Complexity: simple
Sentiment: neutral
Topics: executive-changes, compensation, corporate-governance
TL;DR
**CRL just filed an 8-K about executive changes and pay, keep an eye out for details.**
AI Summary
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) filed an 8-K on January 24, 2024, reporting an event that occurred on January 22, 2024, related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.' This filing indicates changes in key personnel or their compensation structures, which could impact the company's strategic direction or financial performance. Investors should monitor subsequent filings for specific details on who departed or was appointed, and how their compensation is structured, as these changes can signal shifts in leadership stability or operational focus.
Why It Matters
Changes in leadership and executive compensation can signal shifts in company strategy, stability, or financial health, directly impacting investor confidence and future stock performance.
Risk Assessment
Risk Level: medium — While the filing itself doesn't detail specific changes, any executive or director departure/appointment carries inherent risks and opportunities for a company's future direction.
Analyst Insight
A smart investor would add CRL to their watchlist and await further detailed disclosures regarding the specific personnel changes and compensation arrangements, as these details will determine the actual impact on the company.
Key Players & Entities
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (company) — the registrant filing the 8-K
- January 22, 2024 (date) — date of the earliest event reported
- January 24, 2024 (date) — date the 8-K was filed
- 001-15943 (other) — Commission File Number
- 06-1397316 (other) — IRS Employer Identification No.
FAQ
What specific event did CHARLES RIVER LABORATORIES INTERNATIONAL, INC. report in this 8-K filing?
The 8-K reported an event concerning 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers' as per the Item Information.
When did the earliest event reported in this 8-K filing occur?
The earliest event reported in this 8-K filing occurred on January 22, 2024, as stated in the 'Date of Report (Date of earliest event reported)' section.
What is the trading symbol and exchange for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. common stock?
The common stock of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. trades under the symbol 'CRL' on the New York Stock Exchange, as indicated in the 'Securities registered pursuant to Section 12(b) of the Act' section.
What is the business address of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.?
The business address of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. is 251 Ballardvale Street, Wilmington, Massachusetts 01887.
Under which SEC Act and Section was this Form 8-K filed?
This Form 8-K was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 733 words · 3 min read · ~2 pages · Grade level 12.5 · Accepted 2024-01-24 16:34:01
Key Financial Figures
- $0.01 — ange on which registered Common stock, $0.01 par value CRL New York Stock Exchange
- $255,500 — ore pro-rata adjustment) has a value of $255,500 and will be issued in the form of 50% r
Filing Documents
- crl-20240122.htm (8-K) — 24KB
- 0001100682-24-000004.txt ( ) — 147KB
- crl-20240122.xsd (EX-101.SCH) — 2KB
- crl-20240122_lab.xml (EX-101.LAB) — 24KB
- crl-20240122_pre.xml (EX-101.PRE) — 12KB
- crl-20240122_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Date: January 24, 2024 By: /s/ Matthew L. Daniel Matthew L. Daniel, Corporate Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer 3